Cardiology

Special Issues

Following special issues within this section are currently open for submissions:

• Cardiovascular Rehabilitation (Deadline: 31 May 2020)
• New Pathophysiological Pathways and the Role and Relevance of Novel Diagnosis and Treatment Tools Targeting the Sympathetic Nervous System in Patients with Heart Failure (Deadline: 30 June 2020)
• Epidemiology, Diagnosis, Pathophysiology, Risk Stratification, and Therapy of Heart Failure with Preserved Ejection Fraction (Deadline: 30 June 2020)
• Diagnosis and Treatment of Patients with Angina (Deadline: 30 June 2020)
• Characterization and Clinical Management of Dilated Cardiomyopathy (Deadline: 31 July 2020)
• Coronary Artery Disease: The Role of Sex (Deadline: 31 July 2020)
• Cardiovascular Disease: New Generation of Biomarkers and Future Therapeutic Concepts (Deadline: 31 August 2020)
• Myocardial Infarction and Myocardial Injury in Acute Cardiac Care (Deadline: 31 August 2020)
• Early Diagnosis, Monitoring, Prevention and Treatment of Cardiotoxicity (Deadline: 31 August 2020)
• The Role of Cardiac Imaging in the Evaluation of Cardiac Involvement in Systemic and Neuromuscular Diseases (Deadline: 31 August 2020)
• The Diagnosis and Management of Cardiovascular Disease in Cancer Patients (Deadline: 30 September 2020)
• Diagnosis and Treatment of Myocardial Infarction (Deadline: 20 November 2020)
• Recent Advances in Coronary Artery Disease (Deadline: 30 November 2020)
• Cardiovascular Precision Medicine (Deadline: 30 November 2020)
• The Management of Chronic Heart Failure and Hypertension (Deadline: 15 December 2020)
• New Perspective in Atrial Fibrillation (Deadline: 20 December 2020)
• New Frontiers in Cardiovascular Intervention (Deadline: 30 December 2020)
• Recent Advances in Kidney and Cardiovascular Diseases (Deadline: 31 December 2020)
• Acute Coronary Syndromes: Precision Treatment (Deadline: 31 December 2020)
• Protein Kinases in Cardiovascular Pathophysiology (Deadline: 31 December 2020)
• Pharmacological Lipid Strategies for Cardiovascular Disease Prevention (Deadline: 31 December 2020)
• Clinical Management and Prognosis in Dilated Cardiomyopathy (Deadline: 31 December 2020)
• State-of-the-Art: Post-percutaneous Coronary Intervention Pharmacotherapy (Deadline: 31 January 2021)
• Clinical and Research of Genetic Cardiomyopathies (Deadline: 31 January 2021)
• Arrhythmogenic Fibrotic Atrial Cardiomyopathy (FAM) and Atrial Fibrillation: Pathophysiology, Diagnosis, Treatment and Consequences for Prevention of Ischemic Stroke (Deadline: 31 March 2021)